Singapore competition watchdog seeks public feedback on proposed commitments in clinical labs merger

  • 📰 BusinessTimes
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 51%

Nigeria News News

Nigeria Nigeria Latest News,Nigeria Nigeria Headlines

THE Competition and Consumer Commission of Singapore (CCCS) is inviting public feedback on the two-year commitments proposed by Pathology Asia Holdings (PAH) to address competition concerns in the planned merger of two private clinical laboratories. Read more at The Business Times.

THE Competition and Consumer Commission of Singapore is inviting public feedback on the two-year commitments proposed by Pathology Asia Holdings to address competition concerns in the planned merger of two private clinical laboratories.

It said that it is entering into the four commitments even though it “disagrees with the concerns identified by the CCCS”, and that it believes that the merger does not result in substantially reducing competition in any market in Singapore. PAH is also committing to allow early termination of contracts without cause. Likewise, this enables customers to more easily switch to other labs.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 15. in NG

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines